Passage Bio (PASG) Appoints William Chou as CEO streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PHILADELPHIA, Oct. 10, 2022 Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced. | October 10, 2022
/PRNewswire/ Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that Michael W. Kent, M.D.,.
Aruvant Announces Data Presentation at European Hematology Association 2022 Hybrid Congress djournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from djournal.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that data demonstrating the.